News | Interventional Radiology | April 21, 2020

Guerbet Announces FDA Approval to Manufacture Dotarem Injection in the United States

#gadolinium Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture Dotarem (gadoterate meglumine) injection at its Raleigh, N.C., facility

April 21, 2020 — Guerbet announced that it received U.S. Food and Drug Administration (FDA) approval to manufacture Dotarem (gadoterate meglumine) injection at its Raleigh, N.C., facility. Until late 2019, Dotarem was manufactured exclusively outside of the United States. 

Guerbet intends to produce Dotarem within the United States for US-based customers, in alignment with Guerbet’s broader vision to supply US-manufactured products to US customers. Guerbet’s line of power injectors and urology systems are manufactured and/or assembled in Cincinnati, Ohio.

“We are proud to add Dotarem to our list of products manufactured or assembled in the United States for US customers,” reported Thomas McLaughlin, vice president, North America. The Raleigh facility is manufacturing Dotarem  in both vials and plastic syringes. The plastic syringes feature a new pushrod that is designed to make hand injections more ergonomic, and plastic pre-filled syringes reduce patient risks including the chance of contamination as compared to bulk fill containers. The StarClip adapter enables power injection of Dotarem (in the new plastic syringes) using Guerbet’s OptiStar Elite injector. The new, more durable outer packaging allows for both improved convenience and workflow efficiency in the radiology suite.

As a result of U.S. manufacturing approval, customers should refer to the following new product item numbers and NDC codes when ordering new product inventory:

For Dotarem® 10x15mL Vials:
New Item Code: 368220012
New NDC Code: 67684200102

For Dotarem 10x100mL Vials:
New Item Code: 368220014
New NDC Code: 67684200104

For Dotarem 10x20mL Vials:
New Item Code: 368220013
New NDC Code: 67684200103

For Dotarem 20mL Plastic Prefilled Syringe:
New Item Code: 368230013
New NDC Code: 67684300103

All units of measure remain the same except for the Prefilled Syringe (PFS) product line, which has changed from 5/box to 10/case.

These are the first of several SKUs to launch in the U.S. Remaining SKUs will be phased in throughout 2020.

Customers are encouraged to continue using their existing supply of glass syringes with Dotaclip as new syringes with StarClip are introduced. Customers should work with their distribution partners to ensure that correct products are received throughout this transition process.

For more information: www.guerbet.com

Related Content

Important milestone demonstrates the unrivalled experience, technological innovation and global market leadership of IBA and its clinical partners
News | Proton Therapy | September 25, 2020
September 25, 2020 — IBA (Ion Beam Applications SA) announced that more than 100,000 patients have now been treated w
The cartilage in this MRI scan of a knee is colorized to show greater contrast between shades of gray.

The cartilage in this MRI scan of a knee is colorized to show greater contrast between shades of gray. Image courtesy of Kundu et al. (2020) PNAS

News | Artificial Intelligence | September 22, 2020
September 22, 2020 — Researchers at the University of Pitts...
Philips Azurion Lung Edition supports high precision diagnosis and minimally invasive therapy in one room
News | Lung Imaging | September 21, 2020
September 21, 2020 — Philips introduced...
Final rule includes mandatory participation for nearly 1,000 practices and does not allow sufficient time for transition

Getty Images

News | Radiation Oncology | September 21, 2020
September 21, 2020 — In response to the September 18 ...
According to a new report published by P&S Intelligence, the global radiotherapy market is expected to expand from $7.2M in 2019 to $17M by 2030.

Image courtesy of Accuray

Feature | Radiation Therapy | September 21, 2020 | By Melinda Taschetta-Millane
According to a...
A new report, Magnetic Resonance Imaging Equipment Market Size, Share & Industry Analysis, conducted by Fortune Business Insights, states that the magnetic resonance imaging (MRI) equipment market reached $7.24 billion in 2019 and is projected to reach $11.36 billion by 2027

Image courtesy of Siemens Healthineers

Feature | Magnetic Resonance Imaging (MRI) | September 21, 2020 | By Melinda Taschetta-Millane
A new report,...
Breast cancer patients whose disease has spread to their brains fare better if their metastases are picked up before they begin to cause symptoms, according to a study presented at the 12th European Breast Cancer Conference.

Getty Images

News | Breast Imaging | September 21, 2020
September 21, 2020 — Breast cancer patients whose disease has spread to their brains fare better if their metastases
Figure 1. Doppler flows in subpleural consolidation shows smoothly dilated branching arteries

Figure 1. Doppler flows in subpleural consolidation shows smoothly dilated branching arteries 

Feature | Radiology Imaging | September 17, 2020 | By Robert Bard, M.D. PC, DABR, FASLM
COVID-19 is routinely studied using...
Data from latest research presented at the ESMO Virtual Congress 2020 suggests COVID-19 pandemic halts cancer care and damages oncologists' wellbeing

Getty Images

News | Coronavirus (COVID-19) | September 17, 2020
September 17, 2020 — Delays and cancellation of cancer treatments and other safety measures undertaken to minimize th